Our science is solid, our MOA is clear! We have so many indications to come! So far the best phase 2 trials for M/M patients, but our shares are down from $10 to $4. It doesn't make sense for everyone. The reason is we have so many shorties here! We have a war with them! We can't win the shorts alone, but we have 43k of us, if we buy 1000 shares per shareholder, we have 43 million shares! The current total short position is only 13.6 million shares! Even every of us buy 316 shares, shorts have to double their short position! We will win if we all together!